Clinical Trial Update: An Investigation of the Effect of the Promoter Polymorphism in the Glucuronosyltransferase 2B7 in Patients on Breast Cancer Treatment

View source ↗

Summary

A clinical trial examining the effect of a UGT2B7 promoter polymorphism on breast cancer treatment was terminated.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer

Snippet

Sponsor: AHS Cancer Control Alberta | Conditions: Breast Cancer | Status: TERMINATED